Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia
Key facts
- Who runs it
- Yin Ping
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 264 people, planned
- Started
- 20 Oct 2022
- Ended
- 1 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Acupuncture
- Sham acupuncture
- Record updated
- 22 May 2025
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- Meet the diagnostic criteria for breast cancer in the 2022 V2 edition of the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology and the American Joint Committee on Cancer (AJCC) Cancer Staging Manual (8th edition) for breast cancer staging criteria meet the diagnostic criteria for breast cancer with TNM stage I to III; meet the diagnostic criteria for insomnia within the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and insomnia related to the cancer itself or to cancer-related treatment occurred after breast cancer diagnosis and lasted for at least 1 month
- Female patients aged 18-75 years
- Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
- Sleep severity index scale (ISI) score ≥ 8
- Predicted survival of ≥ 6 months
- Patients had never received acupuncture treatment
- No mental or intellectual abnormalities, able to understand the provisions of the scales and complete the assessment
- Consent to participate in this study and sign a written informed consent
Who cannot take part
- Those with planned surgery during the trial
- Previous history of drug abuse or addiction
- Those who have taken sedative-hypnotic drugs or antipsychotic drugs 2 weeks prior to the baseline visit, or received other treatment for insomnia (e.g., cognitive behavioral therapy, etc.) 3 months prior to the baseline visit, which may affect the efficacy of the observation
- Combination of more serious heart, liver, kidney, and other major diseases. f applicable, indicate if participant eligibility is based on self-representation of gender identity
- Insomnia due to cancer pain with an numeric rating scale (NRS) score ≥ 4, or insomnia due to other physical diseases
- Ulcers, abscesses, skin infections, etc. at the site of needling
- Patients who are pregnant or breastfeeding
- Long-term night work or irregular rest and relaxation
- Participation in other clinical medical trial studies within the last month
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Through a scientific and standardized multicenter, randomized, and controlled study method, the investigators evaluated the clinical efficacy and safety of acupuncture in the treatment of breast cancer-related insomnia, with a view to providing a reliable theoretical basis for the treatment of breast cancer-related insomnia with acupuncture.
The 2 groups in the trial
- Acupuncture groupTreatment being tested
Participants will be given sleep hygiene instructions. Participants will receive acupuncture treatment at Nei Guan (PC 6), Shen Men (HT 7), Shen Ting (GV 24), Yin Tang (GV 29), Zhong Wan (CV 12), San Yin Jiao (SP 6), Zhao Hai (KI 6), and Shen Mai (BL 62). Among the above acupoints, Nei Guan (PC 6), Shen Men (HT 7), San Yin Jiao (SP 6), Zhao Hai (KI 6), and Shen Mai (BL 62) are all taken from both sides. Participants will receive three treatments per week (every other day), each lasting 30 minutes, for a total of 12 sessions over the course of four weeks. The follow-up observation will be recorded on week 8 and 16.
Treatment: Acupuncture
- Sham acupuncture groupSham treatment, for comparison
Participants will be given sleep hygiene instructions. To match the true acupuncture points, sham treatment at sham Nei Guan (PC 6), Shen Men (HT 7), Shen Ting (GV 24), Yin Tang (GV 29), Zhong Wan (CV 12), San Yin Jiao (SP 6), Zhao Hai (KI 6), and Shen Mai (BL 62) will be used. Participants will have the same needle retention time, treatment time, and follow-up time as the acupuncture group.
Treatment: Sham acupuncture
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Acupuncture for Breast Cancer-related Insomnia : a Multicenter Randomized Controlled Clinical Trial
- Publications
- Record updated
- 22 May 2025